Rothman joins Medtronic's vascular unit as VP of medical affairs
This article was originally published in Clinica
Executive Summary
Medtronic has appointed Prof Martin Rothman vice-president of medical affairs for its Santa Rosa, California-based coronary and peripheral vascular division, effective January 4 2010. Prof Rothman has worked as an interventional cardiologist in the UK for 37 years, contributing to clinical research (he was an investigator in clinical trials of Medtronic's Endeavor drug-eluting stents), training and education and new product development. His first start-up company, set up in 1985, developed intravascular ultrasound technology that allows clinicians to see inside patients’ arteries – the company was sold in May 2000.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.